{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:46:06Z","timestamp":1773297966831,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1038\/npp.2017.269","type":"journal-article","created":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T12:00:35Z","timestamp":1509537635000},"page":"1436-1444","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Neuroactive Steroids and Affective Symptoms in Women Across the Weight Spectrum"],"prefix":"10.1038","volume":"43","author":[{"given":"Laura E","family":"Dichtel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Schorr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erinne","family":"Meenaghan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret Lederfine","family":"Paskal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamryn T","family":"Eddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graziano","family":"Pinna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianela","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann M","family":"Rasmusson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Klibanski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen K","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,1]]},"reference":[{"key":"BFnpp2017269_CR1","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1007\/s00213-014-3567-5","volume":"231","author":"RC Agis-Balboa","year":"2014","unstructured":"Agis-Balboa RC, Guidotti A, Pinna G (2014). 5alpha-reductase type I expression is downregulated in the prefrontal cortex\/Brodmann's area 9 (BA9) of depressed patients. Psychopharmacology (Berl) 231: 3569\u20133580.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2017269_CR2","unstructured":"American Psychiatric Association (2000) Diagnostic Statistical Manual of Mental Disorders. American Psychiatric Publishing: Arlington, VA, USA. 4th edn."},{"key":"BFnpp2017269_CR3","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Publishing: Arlington, VA, USA. 5th edn.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"BFnpp2017269_CR4","first-page":"57","volume":"102","author":"KN Bachmann","year":"2016","unstructured":"Bachmann KN, Schorr M, Bruno AG, Bredella MA, Lawson EA, Gill CM et al (2016). Vertebral volumetric bone density and strength are impaired in women with low-weight and atypical anorexia nervosa. J Clin Endocrinol Metab 102: 57\u201368.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFnpp2017269_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.bone.2014.06.014","volume":"66","author":"MA Bredella","year":"2014","unstructured":"Bredella MA, Fazeli PK, Daley SM, Miller KK, Rosen CJ, Klibanski A et al (2014). Marrow fat composition in anorexia nervosa. Bone 66: 199\u2013204.","journal-title":"Bone"},{"key":"BFnpp2017269_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1530\/EJE-10-0365","volume":"163","author":"DJ Brick","year":"2010","unstructured":"Brick DJ, Gerweck AV, Meenaghan E, Lawson EA, Misra M, Fazeli P et al (2010). Determinants of IGF1 and GH across the weight spectrum: from anorexia nervosa to obesity. Eur J Endocrinol 163: 185\u2013191.","journal-title":"Eur J Endocrinol"},{"key":"BFnpp2017269_CR7","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2105\/AJPH.90.2.251","volume":"90","author":"KM Carpenter","year":"2000","unstructured":"Carpenter KM, Hasin DS, Allison DB, Faith MS (2000). Relationships between obesity and DSM-IV major depressive disorder, suicide ideation, and suicide attempts: results from a general population study. Am J Public Health 90: 251\u2013257.","journal-title":"Am J Public Health"},{"key":"BFnpp2017269_CR8","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.1523\/JNEUROSCI.15-06-04641.1995","volume":"15","author":"DL Cheney","year":"1995","unstructured":"Cheney DL, Uzunov D, Costa E, Guidotti A (1995a). Gas chromatographic-mass fragmentographic quantitation of 3 alpha-hydroxy-5 alpha-pregnan-20-one (allopregnanolone) and its precursors in blood and brain of adrenalectomized and castrated rats. J Neurosci 15: 4641\u20134650.","journal-title":"J Neurosci"},{"key":"BFnpp2017269_CR9","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1097\/00001756-199508000-00025","volume":"6","author":"DL Cheney","year":"1995","unstructured":"Cheney DL, Uzunov D, Guidotti A (1995b). Pregnenolone sulfate antagonizes dizocilpine amnesia: role for allopregnanolone. Neuroreport 6: 1697\u20131700.","journal-title":"Neuroreport"},{"key":"BFnpp2017269_CR10","doi-asserted-by":"publisher","first-page":"13925","DOI":"10.1073\/pnas.240269897","volume":"97","author":"JL Do-Rego","year":"2000","unstructured":"Do-Rego JL, Mensah-Nyagan GA, Beaujean D, Vaudry D, Sieghart W, Luu-The V et al (2000). gamma-Aminobutyric acid, acting through gamma -aminobutyric acid type A receptors, inhibits the biosynthesis of neurosteroids in the frog hypothalamus. Proc Natl Acad Sci USA 97: 13925\u201313930.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2017269_CR11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1515\/HMBCI.2010.010","volume":"1","author":"M Duskova","year":"2010","unstructured":"Duskova M, Hill M, Starka L (2010). The influence of low dose finasteride, a type II 5alpha-reductase inhibitor, on circulating neuroactive steroids. Horm Mol Biol Clin Investig 1: 95\u2013102.","journal-title":"Horm Mol Biol Clin Investig"},{"key":"BFnpp2017269_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4088\/JCP.13m08753","volume":"76","author":"KT Eddy","year":"2015","unstructured":"Eddy KT, Lawson EA, Meade C, Meenaghan E, Horton SE, Misra M et al (2015). Appetite regulatory hormones in women with anorexia nervosa: binge-eating\/purging versus restricting type. J Clin Psychiatry 76: 19\u201324.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2017269_CR13","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.neuroscience.2005.07.007","volume":"138","author":"D Eser","year":"2006","unstructured":"Eser D, Romeo E, Baghai TC, di Michele F, Schule C, Pasini A et al (2006a). Neuroactive steroids as modulators of depression and anxiety. Neuroscience 138: 1041\u20131048.","journal-title":"Neuroscience"},{"key":"BFnpp2017269_CR14","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00213-005-0188-z","volume":"186","author":"D Eser","year":"2006","unstructured":"Eser D, Schule C, Romeo E, Baghai TC, di Michele F, Pasini A et al (2006b). Neuropsychopharmacological properties of neuroactive steroids in depression and anxiety disorders. Psychopharmacology (Berl) 186: 373\u2013387.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2017269_CR15","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.physbeh.2009.02.022","volume":"97","author":"CA Frye","year":"2009","unstructured":"Frye CA, Walf AA (2009). Depression-like behavior of aged male and female mice is ameliorated with administration of testosterone or its metabolites. Physiol Behav 97: 266\u2013269.","journal-title":"Physiol Behav"},{"key":"BFnpp2017269_CR16","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S0006-3223(02)01668-2","volume":"53","author":"S Galderisi","year":"2003","unstructured":"Galderisi S, Mucci A, Monteleone P, Sorrentino D, Piegari G, Maj M (2003). Neurocognitive functioning in subjects with eating disorders: the influence of neuroactive steroids. Biol Psychiatry 53: 921\u2013927.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2017269_CR17","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.psyneuen.2011.08.004","volume":"37","author":"SS Girdler","year":"2012","unstructured":"Girdler SS, Lindgren M, Porcu P, Rubinow DR, Johnson JL, Morrow AL (2012). A history of depression in women is associated with an altered GABAergic neuroactive steroid profile. Psychoneuroendocrinology 37: 543\u2013553.","journal-title":"Psychoneuroendocrinology"},{"key":"BFnpp2017269_CR18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","volume":"32","author":"M Hamilton","year":"1959","unstructured":"Hamilton M (1959). The assessment of anxiety states by rating. Br J Med Psychol 32: 50\u201355.","journal-title":"Br J Med Psychol"},{"key":"BFnpp2017269_CR19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M (1960). A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56\u201362.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFnpp2017269_CR20","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0193-953X(05)70385-3","volume":"19","author":"DB Herzog","year":"1996","unstructured":"Herzog DB, Nussbaum KM, Marmor AK (1996). Comorbidity and outcome in eating disorders. Psychiatr Clin North Am 19: 843\u2013859.","journal-title":"Psychiatr Clin North Am"},{"key":"BFnpp2017269_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-5559-2","volume-title":"Neurosteroids and the Nervous System","author":"SR King","year":"2013","unstructured":"King SR (2013) Neurosteroids and the Nervous System. Springer: New York, USA."},{"key":"BFnpp2017269_CR22","doi-asserted-by":"publisher","first-page":"4710","DOI":"10.1210\/jc.2009-1046","volume":"94","author":"EA Lawson","year":"2009","unstructured":"Lawson EA, Donoho D, Miller KK, Misra M, Meenaghan E, Lydecker J et al (2009a). Hypercortisolemia is associated with severity of bone loss and depression in hypothalamic amenorrhea and anorexia nervosa. J Clin Endocrinol Metab 94: 4710\u20134716.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFnpp2017269_CR23","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/j.1365-2265.2011.04182.x","volume":"76","author":"EA Lawson","year":"2012","unstructured":"Lawson EA, Miller KK, Blum JI, Meenaghan E, Misra M, Eddy KT et al (2012). Leptin levels are associated with decreased depressive symptoms in women across the weight spectrum, independent of body fat. Clin Endocrinol 76: 520\u2013525.","journal-title":"Clin Endocrinol"},{"key":"BFnpp2017269_CR24","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.bone.2009.09.005","volume":"46","author":"EA Lawson","year":"2010","unstructured":"Lawson EA, Miller KK, Bredella MA, Phan C, Misra M, Meenaghan E et al (2010). Hormone predictors of abnormal bone microarchitecture in women with anorexia nervosa. Bone 46: 458\u2013463.","journal-title":"Bone"},{"key":"BFnpp2017269_CR25","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1210\/jc.2008-2558","volume":"94","author":"EA Lawson","year":"2009","unstructured":"Lawson EA, Misra M, Meenaghan E, Rosenblum L, Donoho DA, Herzog D et al (2009b). Adrenal glucocorticoid and androgen precursor dissociation in anorexia nervosa. J Clin Endocrinol Metab 94: 1367\u20131371.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFnpp2017269_CR26","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1126\/science.2422758","volume":"232","author":"MD Majewska","year":"1986","unstructured":"Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM (1986). Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232: 1004\u20131007.","journal-title":"Science"},{"key":"BFnpp2017269_CR27","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/pst.210","volume":"5","author":"U Meier","year":"2006","unstructured":"Meier U (2006). A note on the power of Fisher's least significant difference procedure. Pharm Stat 5: 253\u2013263.","journal-title":"Pharm Stat"},{"key":"BFnpp2017269_CR28","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000048228","volume":"75","author":"R Menozzi","year":"2002","unstructured":"Menozzi R, Florio P, Bondi M, Luisi S, Cobellis L, Genazzani AR et al (2002). Increased response of plasma allopregnanolone to corticotropin-releasing hormone in obese patients. Neuroendocrinology 75: 124\u2013129.","journal-title":"Neuroendocrinology"},{"key":"BFnpp2017269_CR29","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1210\/jc.2004-1181","volume":"90","author":"K Miller","year":"2004","unstructured":"Miller K, Grieco K, Klibanski A (2004). Testosterone administration in women with anorexia nervosa. The Journal of clinical endocrinology and metabolism 90: 1428\u20131433.","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"BFnpp2017269_CR30","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1210\/jc.2006-2501","volume":"92","author":"KK Miller","year":"2007","unstructured":"Miller KK, Lawson EA, Mathur V, Wexler TL, Meenaghan E, Misra M et al (2007a). Androgens in women with anorexia nervosa and normal-weight women with hypothalamic amenorrhea. J Clin Endocrinol Metab 92: 1334\u20131339.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFnpp2017269_CR31","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1210\/jc.2011-0380","volume":"96","author":"KK Miller","year":"2011","unstructured":"Miller KK, Meenaghan E, Lawson EA, Misra M, Gleysteen S, Schoenfeld D et al (2011). Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: a randomized, placebo-controlled study. J Clin Endocrinol Metab 96: 2081\u20132088.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFnpp2017269_CR32","doi-asserted-by":"publisher","first-page":"959","DOI":"10.4088\/JCP.v68n0621","volume":"68","author":"KK Miller","year":"2007","unstructured":"Miller KK, Wexler TL, Zha AM, Lawson EA, Meenaghan EM, Misra M et al (2007b). Androgen deficiency: association with increased anxiety and depression symptom severity in anorexia nervosa. J Clin Psychiatry 68: 959\u2013965.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2017269_CR33","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0306-4522(03)00287-2","volume":"120","author":"YA Mitev","year":"2003","unstructured":"Mitev YA, Darwish M, Wolf SS, Holsboer F, Almeida OF, Patchev VK (2003). Gender differences in the regulation of 3 alpha-hydroxysteroid dehydrogenase in rat brain and sensitivity to neurosteroid-mediated stress protection. Neuroscience 120: 541\u2013549.","journal-title":"Neuroscience"},{"key":"BFnpp2017269_CR34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/00006842-200101000-00008","volume":"63","author":"P Monteleone","year":"2001","unstructured":"Monteleone P, Luisi M, Colurcio B, Casarosa E, Ioime R, Genazzani AR et al (2001). Plasma levels of neuroactive steroids are increased in untreated women with anorexia nervosa or bulimia nervosa. Psychosom Med 63: 62\u201368.","journal-title":"Psychosom Med"},{"key":"BFnpp2017269_CR35","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1002\/eat.10199","volume":"34","author":"P Monteleone","year":"2003","unstructured":"Monteleone P, Luisi M, De Filippis G, Colurcio B, Genazzani AR, Maj M (2003). Circulating levels of neuroactive steroids in patients with binge eating disorder: a comparison with nonobese healthy controls and non-binge eating obese subjects. Int J Eat Disord 34: 432\u2013440.","journal-title":"Int J Eat Disord"},{"key":"BFnpp2017269_CR36","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/0014-2999(87)90094-X","volume":"142","author":"AL Morrow","year":"1987","unstructured":"Morrow AL, Suzdak PD, Paul SM (1987). Steroid hormone metabolites potentiate GABA receptor-mediated chloride ion flux with nanomolar potency. Eur J Pharmacol 142: 483\u2013485.","journal-title":"Eur J Pharmacol"},{"key":"BFnpp2017269_CR37","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.abb.2007.04.024","volume":"464","author":"TM Penning","year":"2007","unstructured":"Penning TM, Drury JE (2007). Human aldo-keto reductases: function, gene regulation, and single nucleotide polymorphisms. Arch Biochem Biophys 464: 241\u2013250.","journal-title":"Arch Biochem Biophys"},{"key":"BFnpp2017269_CR38","doi-asserted-by":"publisher","first-page":"5567","DOI":"10.1073\/pnas.0801853105","volume":"105","author":"F Pibiri","year":"2008","unstructured":"Pibiri F, Nelson M, Guidotti A, Costa E, Pinna G (2008). Decreased corticolimbic allopregnanolone expression during social isolation enhances contextual fear: a model relevant for posttraumatic stress disorder. Proc Natl Acad Sci USA 105: 5567\u20135572.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2017269_CR39","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/S0028-3908(99)00149-5","volume":"39","author":"G Pinna","year":"2000","unstructured":"Pinna G, Uzunova V, Matsumoto K, Puia G, Mienville JM, Costa E et al (2000). Brain allopregnanolone regulates the potency of the GABA(A) receptor agonist muscimol. Neuropharmacology 39: 440\u2013448.","journal-title":"Neuropharmacology"},{"key":"BFnpp2017269_CR40","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.biopsych.2006.03.026","volume":"60","author":"AM Rasmusson","year":"2006","unstructured":"Rasmusson AM, Pinna G, Paliwal P, Weisman D, Gottschalk C, Charney D et al (2006). Decreased cerebrospinal fluid allopregnanolone levels in women with posttraumatic stress disorder. Biol Psychiatry 60: 704\u2013713.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2017269_CR41","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.neuroscience.2004.08.002","volume":"129","author":"DS Reddy","year":"2004","unstructured":"Reddy DS (2004). Testosterone modulation of seizure susceptibility is mediated by neurosteroids 3alpha-androstanediol and 17beta-estradiol. Neuroscience 129: 195\u2013207.","journal-title":"Neuroscience"},{"key":"BFnpp2017269_CR42","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/B978-0-444-53630-3.00008-7","volume":"186","author":"DS Reddy","year":"2010","unstructured":"Reddy DS (2010). Neurosteroids: endogenous role in the human brain and therapeutic potentials. Prog Brain Res 186: 113\u2013137.","journal-title":"Prog Brain Res"},{"key":"BFnpp2017269_CR43","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1176\/ajp.155.7.910","volume":"155","author":"E Romeo","year":"1998","unstructured":"Romeo E, Strohle A, Spalletta G, di Michele F, Hermann B, Holsboer F et al (1998). Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry 155: 910\u2013913.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2017269_CR44","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S0166-2236(99)01399-5","volume":"22","author":"R Rupprecht","year":"1999","unstructured":"Rupprecht R, Holsboer F (1999a). Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci 22: 410\u2013416.","journal-title":"Trends Neurosci"},{"key":"BFnpp2017269_CR45","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0039-128X(98)00101-9","volume":"64","author":"R Rupprecht","year":"1999","unstructured":"Rupprecht R, Holsboer F (1999b). Neuropsychopharmacological properties of neuroactive steroids. Steroids 64: 83\u201391.","journal-title":"Steroids"},{"key":"BFnpp2017269_CR46","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/eat.22603","volume":"50","author":"M Schorr","year":"2016","unstructured":"Schorr M, Thomas JJ, Eddy KT, Dichtel LE, Lawson EA, Meenaghan E et al (2016). Bone density, body composition, and psychopathology of anorexia nervosa spectrum disorders in DSM-IV vs DSM-5. Int J Eat Disord 50: 343\u2013351.","journal-title":"Int J Eat Disord"},{"key":"BFnpp2017269_CR47","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.psyneuen.2007.04.004","volume":"32","author":"C Schule","year":"2007","unstructured":"Schule C, Baghai TC, di Michele F, Eser D, Pasini A, Schwarz M et al (2007). Effects of combination treatment with mood stabilizers and mirtazapine on plasma concentrations of neuroactive steroids in depressed patients. Psychoneuroendocrinology 32: 669\u2013680.","journal-title":"Psychoneuroendocrinology"},{"key":"BFnpp2017269_CR48","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.pneurobio.2013.09.003","volume":"113","author":"C Schule","year":"2014","unstructured":"Schule C, Nothdurfter C, Rupprecht R (2014). The role of allopregnanolone in depression and anxiety. Prog Neurobiol 113: 79\u201387.","journal-title":"Prog Neurobiol"},{"key":"BFnpp2017269_CR49","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0022-4731(79)90285-1","volume":"11","author":"L Siekmann","year":"1979","unstructured":"Siekmann L (1979). Determination of steroid hormones by the use of isotope dilution\u2014mass spectrometry: a definitive method in clinical chemistry. J Steroid Biochem 11: 117\u2013123.","journal-title":"J Steroid Biochem"},{"key":"BFnpp2017269_CR50","doi-asserted-by":"publisher","first-page":"40224","DOI":"10.1074\/jbc.R112.386664","volume":"287","author":"E Sigel","year":"2012","unstructured":"Sigel E, Steinmann ME (2012). Structure, function, and modulation of GABA(A) receptors. J Biol Chem 287: 40224\u201340231.","journal-title":"J Biol Chem"},{"key":"BFnpp2017269_CR51","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/S0006-3223(98)00328-X","volume":"45","author":"A Strohle","year":"1999","unstructured":"Strohle A, Romeo E, Hermann B, Pasini A, Spalletta G, di Michele F et al (1999). Concentrations of 3 alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery. Biol Psychiatry 45: 274\u2013277.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2017269_CR52","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1073\/pnas.95.6.3239","volume":"95","author":"V Uzunova","year":"1998","unstructured":"Uzunova V, Sheline Y, Davis JM, Rasmusson A, Uzunov DP, Costa E et al (1998). Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci USA 95: 3239\u20133244.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2017269_CR53","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1210\/jc.2003-032006","volume":"89","author":"C Wang","year":"2004","unstructured":"Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto A, Snyder P et al (2004). Long-term testosterone gel (Androgel) treatment maintains beneficial effects on sexual function on mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab 89: 2085\u20132098.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFnpp2017269_CR54","first-page":"2839","volume":"85","author":"C Wang","year":"2000","unstructured":"Wang C, Swedloff R, Iranmanesh A, Dobs A, Snyder P, Cunningham G et al (2000). Transdermal testosterone gel imprvoes sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. Testostrerone Gel Study Group. J Clin Endocrinol Metab 85: 2839\u20132853.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2017269.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2017269","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/npp.2017.269","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/npp2017269.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T06:23:51Z","timestamp":1719555831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2017269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,1]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["BFnpp2017269"],"URL":"https:\/\/doi.org\/10.1038\/npp.2017.269","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,1]]},"assertion":[{"value":"22 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}